Literature DB >> 24106266

CaMKIIδ-dependent inhibition of cAMP-response element-binding protein activity in vascular smooth muscle.

Yongfeng Liu1, Li-Yan Sun1, Diane V Singer1, Roman Ginnan1, Harold A Singer2.   

Abstract

One transcription factor mediator of Ca(2+)-signals is cAMP response element-binding protein (CREB). CREB expression and/or activity negatively correlates with vascular smooth muscle (VSM) cell proliferation and migration. Multifunctional Ca(2+)/calmodulin-dependent protein kinases, including CaMKII, have been demonstrated to regulate CREB activity through both positive and negative phosphorylation events in vitro, but the function of CaMKII as a proximal regulator of CREB in intact cell systems, including VSM, is not clear. In this study, we used gain- and loss-of-function approaches to determine the function of CaMKIIδ in regulating CREB phosphorylation, localization, and activity in VSM. Overexpression of constitutively active CaMKIIδ specifically increased CREB phosphorylation on Ser(142) and silencing CaMKIIδ expression by siRNA or blocking endogenous CaMKII activity with KN93 abolished thrombin- or ionomycin-induced CREB phosphorylation on Ser(142) without affecting Ser(133) phosphorylation. CREB-Ser(142) phosphorylation correlated with transient nucleocytoplasmic translocation of CREB. Thrombin-induced CREB promoter activity, CREB binding to Sik1 and Rgs2 promoters, and Sik1/Rgs2 transcription were enhanced by a kinase-negative CaMKIIδ2 (K43A) mutant and inhibited by a constitutively active (T287D) mutant. Taken together, these studies establish negative regulation of CREB activity by endogenous CaMKIIδ-dependent CREB-Ser(142) phosphorylation and suggest a potential mechanism for CaMKIIδ/CREB signaling in modulating proliferation and migration in VSM cells.

Entities:  

Keywords:  CREB; CaMKII; Calcium; RGS2; SIK1; Thrombin; Vascular Smooth Muscle Cells

Mesh:

Substances:

Year:  2013        PMID: 24106266      PMCID: PMC3837101          DOI: 10.1074/jbc.M113.490870

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus.

Authors:  Eishichi Miyamoto
Journal:  J Pharmacol Sci       Date:  2006       Impact factor: 3.337

2.  KN-93, an inhibitor of multifunctional Ca++/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart.

Authors:  M E Anderson; A P Braun; Y Wu; T Lu; Y Wu; H Schulman; R J Sung
Journal:  J Pharmacol Exp Ther       Date:  1998-12       Impact factor: 4.030

3.  Novel and uncommon isoforms of the calcium sensing enzyme calcium/calmodulin dependent protein kinase II in heart tissue.

Authors:  P Mayer; M Möhlig; D Idlibe; A Pfeiffer
Journal:  Basic Res Cardiol       Date:  1995 Sep-Oct       Impact factor: 17.165

4.  Identification and characterization of delta B-CaM kinase and delta C-CaM kinase from rat heart, two new multifunctional Ca2+/calmodulin-dependent protein kinase isoforms.

Authors:  C F Edman; H Schulman
Journal:  Biochim Biophys Acta       Date:  1994-03-10

5.  Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary artery smooth muscle cells.

Authors:  Chrystelle V Garat; Dana Fankell; Paul F Erickson; Jane E-B Reusch; Natalie N Bauer; Ivan F McMurtry; Dwight J Klemm
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 6.  Excitation-transcription coupling in smooth muscle.

Authors:  Christy A Barlow; Patricia Rose; Renee A Pulver-Kaste; Karen M Lounsbury
Journal:  J Physiol       Date:  2005-10-13       Impact factor: 5.182

Review 7.  Excitation-transcription coupling in arterial smooth muscle.

Authors:  Brian R Wamhoff; Douglas K Bowles; Gary K Owens
Journal:  Circ Res       Date:  2006-04-14       Impact factor: 17.367

8.  Identification of novel isoforms of the delta subunit of Ca2+/calmodulin-dependent protein kinase II. Differential expression in rat brain and aorta.

Authors:  C M Schworer; L I Rothblum; T J Thekkumkara; H A Singer
Journal:  J Biol Chem       Date:  1993-07-05       Impact factor: 5.157

9.  Differential activation of CREB by Ca2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity.

Authors:  P Sun; H Enslen; P S Myung; R A Maurer
Journal:  Genes Dev       Date:  1994-11-01       Impact factor: 11.361

10.  Alternative splicing introduces a nuclear localization signal that targets multifunctional CaM kinase to the nucleus.

Authors:  M Srinivasan; C F Edman; H Schulman
Journal:  J Cell Biol       Date:  1994-08       Impact factor: 10.539

View more
  11 in total

1.  Ca2+/calmodulin-dependent protein kinase II-γ (CaMKIIγ) negatively regulates vascular smooth muscle cell proliferation and vascular remodeling.

Authors:  Fatima Z Saddouk; Li-Yan Sun; Yong Feng Liu; Miao Jiang; Diane V Singer; Johannes Backs; Dee Van Riper; Roman Ginnan; John J Schwarz; Harold A Singer
Journal:  FASEB J       Date:  2015-11-13       Impact factor: 5.191

Review 2.  Vascular CaMKII: heart and brain in your arteries.

Authors:  Fanny Toussaint; Chimène Charbel; Bruce G Allen; Jonathan Ledoux
Journal:  Am J Physiol Cell Physiol       Date:  2016-06-15       Impact factor: 4.249

3.  Role of CaMKII in Ang-II-dependent small artery remodeling.

Authors:  Anand M Prasad; Pimonrat Ketsawatsomkron; Daniel W Nuno; Olha M Koval; Megan E Dibbern; Ashlee N Venema; Curt D Sigmund; Kathryn G Lamping; Isabella M Grumbach
Journal:  Vascul Pharmacol       Date:  2016-09-20       Impact factor: 5.773

4.  Thymine DNA glycosylase is a key regulator of CaMKIIγ expression and vascular smooth muscle phenotype.

Authors:  YongFeng Liu; Li-Yan Sun; Diane V Singer; Roman Ginnan; Wen Zhao; Frances L Jourd'heuil; David Jourd'heuil; Xiaochun Long; Harold A Singer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-09-13       Impact factor: 4.733

5.  CaMKII (Ca2+/Calmodulin-Dependent Kinase II) in Mitochondria of Smooth Muscle Cells Controls Mitochondrial Mobility, Migration, and Neointima Formation.

Authors:  Emily K Nguyen; Olha M Koval; Paige Noble; Kim Broadhurst; Chantal Allamargot; Meng Wu; Stefan Strack; William H Thiel; Isabella M Grumbach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03-29       Impact factor: 8.311

6.  Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.

Authors:  Anand M Prasad; Donald A Morgan; Daniel W Nuno; Pimonrat Ketsawatsomkron; Thomas B Bair; Ashlee N Venema; Megan E Dibbern; William J Kutschke; Robert M Weiss; Kathryn G Lamping; Mark W Chapleau; Curt D Sigmund; Kamal Rahmouni; Isabella M Grumbach
Journal:  J Am Heart Assoc       Date:  2015-06-15       Impact factor: 5.501

7.  CAMKII as a therapeutic target for growth factor-induced retinal and choroidal neovascularization.

Authors:  Sadaf Ashraf; Samuel Bell; Caitriona O'Leary; Paul Canning; Ileana Micu; Jose A Fernandez; Michael O'Hare; Peter Barabas; Hannah McCauley; Derek P Brazil; Alan W Stitt; J Graham McGeown; Tim M Curtis
Journal:  JCI Insight       Date:  2019-03-21

Review 8.  The Role of Calmodulin in Tumor Cell Migration, Invasiveness, and Metastasis.

Authors:  Antonio Villalobo; Martin W Berchtold
Journal:  Int J Mol Sci       Date:  2020-01-24       Impact factor: 5.923

Review 9.  What turns CREB on? And off? And why does it matter?

Authors:  André Steven; Michael Friedrich; Paul Jank; Nadine Heimer; Jan Budczies; Carsten Denkert; Barbara Seliger
Journal:  Cell Mol Life Sci       Date:  2020-04-28       Impact factor: 9.261

10.  MicroRNA-30 inhibits neointimal hyperplasia by targeting Ca(2+)/calmodulin-dependent protein kinase IIδ (CaMKIIδ).

Authors:  Yong Feng Liu; Amy Spinelli; Li-Yan Sun; Miao Jiang; Diane V Singer; Roman Ginnan; Fatima Z Saddouk; Dee Van Riper; Harold A Singer
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.